Trial Profile
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary)
- Indications Aspergillosis; Candidaemia; Candidiasis
- Focus Pharmacokinetics
- Acronyms CaspoKin
- 12 Jun 2019 Status changed from recruiting to completed.
- 09 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Feb 2018.
- 09 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Feb 2018.